Global Recombinant Protein Market Size, Trends, Opportunity, Outlook & Forecast 2018-2023

Global Recombinant Protein Market Size, Trends, Opportunity, Outlook & Forecast 2018-2023

  1. Published: Nov 2018
  2. Category: Food
  3. Format: PDF/PPT
  4. Report Code: KDMI1607

Report Introduction:

KD market research provides a forecast for global Recombinant Protein Market for a span of 6 years i.e. between 2018 and 2023. In terms of value, market is going to register a 6.6% CAGR during the forecast years. The provided research provides the market trends and dynamics across seven regions: North America, Latin America, Europe, APAC and Middle East & Africa. These regions influence both current and future status for Recombinant Protein Market over the forecast period.

Report Description:

Recombinant Protein research provides a detailed analysis of its global market and insights that is sole reason behind the popularity of Recombinant Protein technology and its advantages. The report covers detailed analysis of key industry drivers, challenges, market trends as well as market structure. The report has been segregated on the basis of Product, Application and End User. This research also provides an assessment of key stakeholders and their strategies that helps them to succeed in business.

The market of recombinant protein is expected to grow on the back of factors such as growing application of recombinant protein in areas such as research, biotechnology and others. Further, uses of recombinant protein in therapies for a variety of diseases, such as diabetes, cancer, infectious diseases, hemophilia, and anemia is a major driving factor of global recombinant protein market. Additionally, these proteins are also used in application such as food production, agriculture, and bioengineering. In addition to this, advancement in technologies in various areas associated with or facilitating recombinant protein production is likely to support the growth of recombinant protein market globally.

Classification of Recombinant Protein is based on Product, Application and End User. On the basis of Product market is sub segmented into Immune Checkpoint Proteins, Cytokines, Chemokines, Colony Stimulating Factors, Growth Factors, Hormones & Enzymes, Viral Protein, Others. On the basis of Application market is sub segmented into Medicine, Research, Biotechnology. On the basis of End User market is sub segmented into Biopharmaceutical Companies, Research Organizations & Laboratories, Food & Beverage Companies, Diagnostic Centers, Others.

Report provides detailed analysis for every segment in terms of market size for the Recombinant Protein Market across different regions. This section also provides a deep analysis that covers key trends of the industry.

Coming to next segment, report provides an analysis of Recombinant Protein Market for global countries in the region. It covers a market overview for 2018-2023 and gives probable forecast with the context of Recombinant Protein market. This also covers new technological development and their role in the market. The research covers the pivotal trends within countries contributing to growth of the market, as well as analyses the factors due to which drivers impact the market in each region. Key regions and countries included in this report includes North America (U.S. & Canada), Latin America (Brazil, Mexico, Argentina and Rest of Latin America), Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe), APAC (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific) and MEA (GCC, North Africa, South Africa and Rest of Middle East & Africa).

This report evaluates the current scenario and the growth objective of the Recombinant Protein Market across various regions globally for the period 2018 –2023. We have considered 2017 as the base year and provided data for the remaining 12 months.

As already mentioned, the global Recombinant Protein Market is divided into a number of segments. All segments in terms of Product, Application, End User and different regions are examined in terms of base points to understand the relative contributions of each segments to market growth. This detailed level of facts & information is essential for the identification of various key factors in the global Recombinant Protein market.

In the final section of the report, we have included a competitive landscape to provide clients a dashboard view based on categories of providers in the value chain, their presence in the Recombinant Protein market, and key differentiators. This section is mainly designed to provide clients an objective and detailed comparative assessment of key providers specific to a market segment in the Recombinant Protein supply chain and the main competitors for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on the in-depth assessment of capabilities and success in the marketplace. Detailed profiles of providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings, and recent developments in the Recombinant Protein market. Some of the key competitors covered in the report are Abcam plc, A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories, Inc., BPS Bioscience Inc., PerkinElmer Inc., Crown Bioscience, Inc., Prospec-Tany Technogene Ltd., Merck Millipore Limited, Sigma Aldrich, Thermo Fisher Scientific, Inc., Other Major & Niche Players.

  By Product

- Immune Checkpoint Proteins

- Cytokines

- Chemokines

- Colony Stimulating Factors

- Growth Factors

- Hormones & Enzymes

- Viral Protein

- Others

By Application

- Medicine

- Research

- Biotechnology

By End-User

- Biopharmaceutical Companies

- Research Organizations & Laboratories

- Food & Beverage Companies

- Diagnostic Centers

- Others

By Geography

- North America (U.S. & Canada)

- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)

- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)

- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)

- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Competitive Landscape

The report profiles various major market players such as:

- Abcam plc

- A.M.S. Biotechnology (Europe) Limited

- Bio-Rad Laboratories, Inc.

- BPS Bioscience Inc.

- PerkinElmer Inc.

- Crown Bioscience, Inc.

- Prospec-Tany Technogene Ltd.

- Merck Millipore Limited

- Sigma Aldrich

- Thermo Fisher Scientific, Inc.

- Other Major & Niche Players

Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, risk analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development expansion and other market activities.

Research Methodology
Market Definition and List of Abbreviations
1. Executive Summary
2. Growth Drivers & Issues in Global Recombinant Protein Market
3. Global Recombinant Protein Market Trends
4. Opportunities in Global Recombinant Protein Market
5. Recent Industry Activities, 2017
6. Porter's Five Forces Analysis
7. Market Value Chain and Supply Chain Analysis
8. Global Recombinant Protein Market Size (USD Million), Growth Analysis and Forecast, (2017-2023)

9. Global Recombinant Protein Market Segmentation Analysis, By Product
9.1. Introduction
9.2. Market Attractiveness, By Product
9.3. BPS Analysis, By Product
9.4. Immune Checkpoint Proteins Market Size & Forecast (USD Million), 2017-2023
9.5. Cytokines Market Size & Forecast (USD Million), 2017-2023
9.6. Chemokines Market Size & Forecast (USD Million), 2017-2023
9.7. Colony Stimulating Factors Market Size & Forecast (USD Million), 2017-2023
9.8. Growth Factors Market Size & Forecast (USD Million), 2017-2023
9.9. Hormones & Enzymes Market Size & Forecast (USD Million), 2017-2023
9.10. Viral Protein Market Size & Forecast (USD Million), 2017-2023
9.11. Others Market Size & Forecast (USD Million), 2017-2023

10. Global Recombinant Protein Market Segmentation Analysis, By Application
10.1. Introduction
10.2. Market Attractiveness, By Application
10.3. BPS Analysis, By Application
10.4. Medicine Market Size & Forecast (USD Million), 2017-2023
10.5. Research Market Size & Forecast (USD Million), 2017-2023
10.6. Biotechnology Market Size & Forecast (USD Million), 2017-2023

11. Global Recombinant Protein Market Segmentation Analysis, By End-User
11.1. Introduction
11.2. Market Attractiveness, By End-User
11.3. BPS Analysis, By End-User
11.4. Biopharmaceutical Companies Market Size & Forecast (USD Million), 2017-2023
11.5. Research Organizations & Laboratories Market Size & Forecast (USD Million), 2017-2023
11.6. Food & Beverage Companies Market Size & Forecast (USD Million), 2017-2023
11.7. Diagnostic Centers Market Size & Forecast (USD Million), 2017-2023
11.8. Others Market Size & Forecast (USD Million), 2017-2023

12. Geographical Analysis
12.1. Introduction
12.2. North America Market Size (USD Million), 2017-2023
12.2.1. By Product
12.2.1.1. Introduction
12.2.1.2. Market Attractiveness, By Product
12.2.1.3. BPS Analysis, By Product
12.2.1.4. Immune Checkpoint Proteins Market Size & Forecast (USD Million), 2017-2023
12.2.1.5. Cytokines Market Size & Forecast (USD Million), 2017-2023
12.2.1.6. Chemokines Market Size & Forecast (USD Million), 2017-2023
12.2.1.7. Colony Stimulating Factors Market Size & Forecast (USD Million), 2017-2023
12.2.1.8. Growth Factors Market Size & Forecast (USD Million), 2017-2023
12.2.1.9. Hormones & Enzymes Market Size & Forecast (USD Million), 2017-2023
12.2.1.10. Viral Protein Market Size & Forecast (USD Million), 2017-2023
12.2.1.11. Others Market Size & Forecast (USD Million), 2017-2023
12.2.2. By Application
12.2.2.1. Introduction
12.2.2.2. Market Attractiveness, By Application
12.2.2.3. BPS Analysis, By Application
12.2.2.4. Medicine Market Size & Forecast (USD Million), 2017-2023
12.2.2.5. Research Market Size & Forecast (USD Million), 2017-2023
12.2.2.6. Biotechnology Market Size & Forecast (USD Million), 2017-2023
12.2.3. By End-User
12.2.3.1. Introduction
12.2.3.2. Market Attractiveness, By End-User
12.2.3.3. BPS Analysis, By End-User
12.2.3.4. Biopharmaceutical Companies Market Size & Forecast (USD Million), 2017-2023
12.2.3.5. Research Organizations & Laboratories Market Size & Forecast (USD Million), 2017-2023
12.2.3.6. Food & Beverage Companies Market Size & Forecast (USD Million), 2017-2023
12.2.3.7. Diagnostic Centers Market Size & Forecast (USD Million), 2017-2023
12.2.3.8. Others Market Size & Forecast (USD Million), 2017-2023
12.2.4. By Country
12.2.4.1. Market Attractiveness, By End-user
12.2.4.2. BPS Analysis, By End-User
12.2.4.3. U.S. Market Size (USD Million), 2017-2023
12.2.4.4. Canada Market Size (USD Million), 2017-2023

12.3. Europe Market Size (USD Million), 2017-2023
12.3.1. By Product
12.3.1.1. Introduction
12.3.1.2. Market Attractiveness, By Product
12.3.1.3. BPS Analysis, By Product
12.3.1.4. Immune Checkpoint Proteins Market Size & Forecast (USD Million), 2017-2023
12.3.1.5. Cytokines Market Size & Forecast (USD Million), 2017-2023
12.3.1.6. Chemokines Market Size & Forecast (USD Million), 2017-2023
12.3.1.7. Colony Stimulating Factors Market Size & Forecast (USD Million), 2017-2023
12.3.1.8. Growth Factors Market Size & Forecast (USD Million), 2017-2023
12.3.1.9. Hormones & Enzymes Market Size & Forecast (USD Million), 2017-2023
12.3.1.10. Viral Protein Market Size & Forecast (USD Million), 2017-2023
12.3.1.11. Others Market Size & Forecast (USD Million), 2017-2023
12.3.2. By Application
12.3.2.1. Introduction
12.3.2.2. Market Attractiveness, By Application
12.3.2.3. BPS Analysis, By Application
12.3.2.4. Medicine Market Size & Forecast (USD Million), 2017-2023
12.3.2.5. Research Market Size & Forecast (USD Million), 2017-2023
12.3.2.6. Biotechnology Market Size & Forecast (USD Million), 2017-2023
12.3.3. By End-User
12.3.3.1. Introduction
12.3.3.2. Market Attractiveness, By End-User
12.3.3.3. BPS Analysis, By End-User
12.3.3.4. Biopharmaceutical Companies Market Size & Forecast (USD Million), 2017-2023
12.3.3.5. Research Organizations & Laboratories Market Size & Forecast (USD Million), 2017-2023
12.3.3.6. Food & Beverage Companies Market Size & Forecast (USD Million), 2017-2023
12.3.3.7. Diagnostic Centers Market Size & Forecast (USD Million), 2017-2023
12.3.3.8. Others Market Size & Forecast (USD Million), 2017-2023
12.3.4. By Country
12.3.4.1. Market Attractiveness, By Country
12.3.4.2. BPS Analysis, By Country
12.3.4.3. Germany Market Size (USD Million), 2017-2023
12.3.4.4. United Kingdom Market Size (USD Million), 2017-2023
12.3.4.5. France Market Size (USD Million), 2017-2023
12.3.4.6. Italy Market Size (USD Million), 2017-2023
12.3.4.7. Spain Market Size (USD Million), 2017-2023
12.3.4.8. Russia Market Size (USD Million), 2017-2023
12.3.4.9. Rest of Europe Market Size (USD Million), 2017-2023

12.4. Asia Pacific Market Size (USD Million), 2017-2023
12.4.1. By Product
12.4.1.1. Introduction
12.4.1.2. Market Attractiveness, By Product
12.4.1.3. BPS Analysis, By Product
12.4.1.4. Immune Checkpoint Proteins Market Size & Forecast (USD Million), 2017-2023
12.4.1.5. Cytokines Market Size & Forecast (USD Million), 2017-2023
12.4.1.6. Chemokines Market Size & Forecast (USD Million), 2017-2023
12.4.1.7. Colony Stimulating Factors Market Size & Forecast (USD Million), 2017-2023
12.4.1.8. Growth Factors Market Size & Forecast (USD Million), 2017-2023
12.4.1.9. Hormones & Enzymes Market Size & Forecast (USD Million), 2017-2023
12.4.1.10. Viral Protein Market Size & Forecast (USD Million), 2017-2023
12.4.1.11. Others Market Size & Forecast (USD Million), 2017-2023
12.4.2. By Application
12.4.2.1. Introduction
12.4.2.2. Market Attractiveness, By Application
12.4.2.3. BPS Analysis, By Application
12.4.2.4. Medicine Market Size & Forecast (USD Million), 2017-2023
12.4.2.5. Research Market Size & Forecast (USD Million), 2017-2023
12.4.2.6. Biotechnology Market Size & Forecast (USD Million), 2017-2023
12.4.3. By End-User
12.4.3.1. Introduction
12.4.3.2. Market Attractiveness, By End-User
12.4.3.3. BPS Analysis, By End-User
12.4.3.4. Biopharmaceutical Companies Market Size & Forecast (USD Million), 2017-2023
12.4.3.5. Research Organizations & Laboratories Market Size & Forecast (USD Million), 2017-2023
12.4.3.6. Food & Beverage Companies Market Size & Forecast (USD Million), 2017-2023
12.4.3.7. Diagnostic Centers Market Size & Forecast (USD Million), 2017-2023
12.4.3.8. Others Market Size & Forecast (USD Million), 2017-2023
12.4.4. By Country
12.4.4.1. Market Attractiveness, By Country
12.4.4.2. BPS Analysis, By Country
12.4.4.3. China Market Size (USD Million), 2017-2023
12.4.4.4. India Market Size (USD Million), 2017-2023
12.4.4.5. Japan Market Size (USD Million), 2017-2023
12.4.4.6. South Korea Market Size (USD Million), 2017-2023
12.4.4.7. Indonesia Market Size (USD Million), 2017-2023
12.4.4.8. Taiwan Market Size (USD Million), 2017-2023
12.4.4.9. Australia Market Size (USD Million), 2017-2023
12.4.4.10. New Zealand Market Size (USD Million), 2017-2023
12.4.4.11. Rest of Asia Pacific Market Size (USD Million), 2017-2023

12.5. Latin America Market Size (USD Million), 2017-2023
12.5.1. By Product
12.5.1.1. Introduction
12.5.1.2. Market Attractiveness, By Product
12.5.1.3. BPS Analysis, By Product
12.5.1.4. Immune Checkpoint Proteins Market Size & Forecast (USD Million), 2017-2023
12.5.1.5. Cytokines Market Size & Forecast (USD Million), 2017-2023
12.5.1.6. Chemokines Market Size & Forecast (USD Million), 2017-2023
12.5.1.7. Colony Stimulating Factors Market Size & Forecast (USD Million), 2017-2023
12.5.1.8. Growth Factors Market Size & Forecast (USD Million), 2017-2023
12.5.1.9. Hormones & Enzymes Market Size & Forecast (USD Million), 2017-2023
12.5.1.10. Viral Protein Market Size & Forecast (USD Million), 2017-2023
12.5.1.11. Others Market Size & Forecast (USD Million), 2017-2023
12.5.2. By Application
12.5.2.1. Introduction
12.5.2.2. Market Attractiveness, By Application
12.5.2.3. BPS Analysis, By Application
12.5.2.4. Medicine Market Size & Forecast (USD Million), 2017-2023
12.5.2.5. Research Market Size & Forecast (USD Million), 2017-2023
12.5.2.6. Biotechnology Market Size & Forecast (USD Million), 2017-2023
12.5.3. By End-User
12.5.3.1. Introduction
12.5.3.2. Market Attractiveness, By End-User
12.5.3.3. BPS Analysis, By End-User
12.5.3.4. Biopharmaceutical Companies Market Size & Forecast (USD Million), 2017-2023
12.5.3.5. Research Organizations & Laboratories Market Size & Forecast (USD Million), 2017-2023
12.5.3.6. Food & Beverage Companies Market Size & Forecast (USD Million), 2017-2023
12.5.3.7. Diagnostic Centers Market Size & Forecast (USD Million), 2017-2023
12.5.3.8. Others Market Size & Forecast (USD Million), 2017-2023
12.5.4. By Country
12.5.4.1. Market Attractiveness, By Country
12.5.4.2. BPS Analysis, By Country
12.5.4.3. Brazil Market Size (USD Million), 2017-2023
12.5.4.4. Mexico Market Size (USD Million), 2017-2023
12.5.4.5. Rest of Latin America Market Size (USD Million), 2017-2023

12.6. Middle East & Africa Market Size (USD Million), 2017-2023
12.6.1. By Product
12.6.1.1. Introduction
12.6.1.2. Market Attractiveness, By Product
12.6.1.3. BPS Analysis, By Product
12.6.1.4. Immune Checkpoint Proteins Market Size & Forecast (USD Million), 2017-2023
12.6.1.5. Cytokines Market Size & Forecast (USD Million), 2017-2023
12.6.1.6. Chemokines Market Size & Forecast (USD Million), 2017-2023
12.6.1.7. Colony Stimulating Factors Market Size & Forecast (USD Million), 2017-2023
12.6.1.8. Growth Factors Market Size & Forecast (USD Million), 2017-2023
12.6.1.9. Hormones & Enzymes Market Size & Forecast (USD Million), 2017-2023
12.6.1.10. Viral Protein Market Size & Forecast (USD Million), 2017-2023
12.6.1.11. Others Market Size & Forecast (USD Million), 2017-2023
12.6.2. By Application
12.6.2.1. Introduction
12.6.2.2. Market Attractiveness, By Application
12.6.2.3. BPS Analysis, By Application
12.6.2.4. Medicine Market Size & Forecast (USD Million), 2017-2023
12.6.2.5. Research Market Size & Forecast (USD Million), 2017-2023
12.6.2.6. Biotechnology Market Size & Forecast (USD Million), 2017-2023
12.6.3. By End-User
12.6.3.1. Introduction
12.6.3.2. Market Attractiveness, By End-User
12.6.3.3. BPS Analysis, By End-User
12.6.3.4. Biopharmaceutical Companies Market Size & Forecast (USD Million), 2017-2023
12.6.3.5. Research Organizations & Laboratories Market Size & Forecast (USD Million), 2017-2023
12.6.3.6. Food & Beverage Companies Market Size & Forecast (USD Million), 2017-2023
12.6.3.7. Diagnostic Centers Market Size & Forecast (USD Million), 2017-2023
12.6.3.8. Others Market Size & Forecast (USD Million), 2017-2023
12.6.4. By Country
12.6.4.1. Market Attractiveness, By Country
12.6.4.2. BPS Analysis, By Country
12.6.4.3. GCC Market Size (USD Million), 2017-2023
12.6.4.4. North Africa Market Size (USD Million), 2017-2023
12.6.4.5. South Africa Market Size (USD Million), 2017-2023
12.6.4.6. Rest of Middle East & Africa Market Size (USD Million), 2017-2023

13. Competitive Landscape
13.1. Market Share of Key Players
13.2. Market Positioning of Major Players in Global Recombinant Protein Market
13.3. Company Profiles
13.3.1. Abcam plc
13.3.2. A.M.S. Biotechnology (Europe) Limited
13.3.3. Bio-Rad Laboratories, Inc.
13.3.4. BPS Bioscience Inc.
13.3.5. PerkinElmer Inc.
13.3.6. Crown Bioscience, Inc.
13.3.7. Prospec-Tany Technogene Ltd.
13.3.8. Merck Millipore Limited
13.3.9. Sigma Aldrich
13.3.10. Thermo Fisher Scientific, Inc.
13.3.11. Other Major & Niche Players

Buy Now

    Select License Type :

  1. $ 3750
  2. $ 4850
  3. $ 5850